Back to Agenda
Reinventing the R&D Business Model: Heeding the President's PCAST Report on Innovation
Session Chair(s)
Kenneth I. Kaitin, PhD
Professor and Senior Fellow
Tufts Center for the Study of Drug Development, United States
The landscape for bioinnovation is changing. This session, hosted by the Tufts Center for the Study of Drug Development (CSDD), will examine how companies across the pharma sector are transforming their R&D business models to meet current and future market demands. This senior-level session represents the cross-functional issues that embrace not just R&D, but preclinical, clinical, regulatory, operations, portfolio management and marketing – all aspects of business development. An executive-level panel will lead this interactive session, which will cover topics including:
* What are the greatest market challenges facing the industry today?
* In what ways are companies adjusting their R&D business models to meet those challenges?
* How has the focus on precision and targeted therapies altered the business model?
* What role do partnerships, alliances and collaborations play in the new bioinnovation landscape?
* How can government further support innovation within the pharma sector?
Learning Objective : Describe the landscape for bioinnovation; Discuss how companies across the pharma sector are transforming their R&D business models to meet current and future market demands.
Speaker(s)
Panelist
Robert J. Franco, PhD
Coe Point Associates LLC, United States
Senior Fellow Tufts CSDD and President
Moderator
Kenneth Getz, MBA
Center For the Study of Drug Development, United States
Tufts Center for the Study of Drug Development
Panelist
Andy Lee, MA
Merck & Co., Inc., United States
Senior Vice President, Head of Global Clinical Trial Operations
Panelist
Bernard Munos, MBA
InnoThink Center for Research in Biomedical Innovation , United States
Founder
Panelist
Tomasz Sablinski, MD, PhD
Transparency Life Sciences, Inc., United States
CEO
Panelist
Dalvir Gill, PhD
TransCelerate BioPharma Inc., United States
Chief Executive Officer
Have an account?